| Effect of COVID-19 on lungs: focusing on prospective malignant phenotypes P Sadhukhan, MT Ugurlu, MO Hoque Cancers 12 (12), 3822, 2020 | 49 | 2020 |
| Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors MK Prelowska, D Mehlich, MT Ugurlu, H Kedzierska, A Cwiek, A Kosnik, ... Cancer Letters 507, 13-25, 2021 | 24 | 2021 |
| Therapeutic targeting of cancer stem cells in lung, head and neck, and bladder cancers SE Mudra, P Sadhukhan, MT Ugurlu, S Alam, MO Hoque Cancers 13 (20), 5098, 2021 | 12 | 2021 |
| Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy M Shibata, A Ooki, Y Inokawa, P Sadhukhan, MT Ugurlu, E Izumchenko, ... Molecular cancer therapeutics 19 (10), 2175-2185, 2020 | 10 | 2020 |
| A novel model of retinopathy of prematurity in normobaric hyperoxic conditions T Ozgurtas, S Tekin, F Yesildal, U Karaca, FN Aydin, MT Ugurlu, M Ozler, ... International Journal of Ophthalmology 9 (9), 1265, 2016 | 7 | 2016 |
| Corrigendum to" Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors"[Canc. Lett. 507 (2021) 13-25] MK Prelowska, D Mehlich, MT Ugurlu, H Kedzierska, A Cwiek, A Kosnik, ... Cancer letters 526, 363, 2022 | 1 | 2022 |
| Abstract P174: YAP1 drives immune suppression in urothelial carcinoma of bladder P Sadhukhan, M Feng, E Illingworth, I Sloma, MT Ugurlu, F Sille, W Choi, ... Molecular Cancer Therapeutics 20 (12_Supplement), P174-P174, 2021 | 1 | 2021 |
| A novel class of Ribosome Modulating Agents (RMAs) target MYC driven SCLC and synergize with DNA intercalating agents V Badarinarayana, M Brait, E Terzo, DG Lima, MT Ugurlu, S Apte, ... European Journal of Cancer 174, S76, 2022 | | 2022 |
| Abstract P094: Targeted sequencing revealed clonal genetic changes in spatially different foci in urothelial carcinoma of bladder MT Ugurlu, R Goldberg, P Sadhukhan, MO Hoque Molecular Cancer Therapeutics 20 (12_Supplement), P094-P094, 2021 | | 2021 |
| Abstract PO-016: Modulating cancer stem cell pathways to enhance systemic therapeutic efficacy P Sadhukhan, M Shibata, MT Ugurlu, R Goldberg, MO Hoque Cancer Research 80 (23_Supplement), PO-016-PO-016, 2020 | | 2020 |
| Regulation of MDSCs in the urothelial carcinoma of bladder: Relevant role of YAP1 P Sadhukhan, MT Ugurlu, A Ooki, M Hoque European Journal of Cancer 138, S61-S62, 2020 | | 2020 |
Mohammad Obaidul Hoque, DDS. Ph.D.Associate Professor of Otolaryngoloy and Head & Neck Surgery, Urology and Oncology在 jhmi.edu 的电子邮件经过验证
